BlueRock Therapeutics company

BlueRock Therapeutics is a biotech company that plans to develop induced pluripotent stem cell (iPSC) therapies to cure a range of diseases using an industry-leading platform. One of the initial programs is to regenerate heart muscle in patients who have had a heart attack (myocard infarction, MI) or are suffering from chronic heart failure, leading causes of morbidity and mortality worldwid.
Technology: Regenerative Medicine
Industry: Biotechnology, Health Care, Science and Engineering
Headquarters: Toronto, Ontario, Canada
Founded Date: 2016-01-01
Employees Number: 101-250
Funding Status: M&A
Investors Number: 3
Total Funding: $34.5M
Estimated Revenue: $1M to $10M
Last Funding Type: Series B

Visit Website
opportunities@bluerocktx.com
https://twitter.com/tenstorrent
Register and Claim Ownership